Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunome (IMNM) Prepaid Assets (2023 - 2025)

Immunome's Prepaid Assets history spans 3 years, with the latest figure at $7.3 million for Q4 2025.

  • For Q4 2025, Prepaid Assets rose 80.75% year-over-year to $7.3 million; the TTM value through Dec 2025 reached $7.3 million, up 80.75%, while the annual FY2025 figure was $7.3 million, 80.75% up from the prior year.
  • Prepaid Assets reached $7.3 million in Q4 2025 per IMNM's latest filing, roughly flat from $7.3 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $9.4 million in Q2 2025 to a low of $253000.0 in Q1 2023.
  • Average Prepaid Assets over 3 years is $4.6 million, with a median of $4.9 million recorded in 2024.
  • The largest YoY upside for Prepaid Assets was 2088.56% in 2024 against a maximum downside of 38.48% in 2024.
  • A 3-year view of Prepaid Assets shows it stood at $6.6 million in 2023, then plummeted by 38.48% to $4.0 million in 2024, then skyrocketed by 80.75% to $7.3 million in 2025.
  • Per Business Quant, the three most recent readings for IMNM's Prepaid Assets are $7.3 million (Q4 2025), $7.3 million (Q3 2025), and $9.4 million (Q2 2025).